SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Markus J. Seibel, Bone Cancer, 2015,

    CrossRef

  2. 2
    Aline G. Costa, Claudio Marcocci, John P. Bilezikian, The Parathyroids, 2015,

    CrossRef

  3. 3
    Je Hoon Jeong, JuRi Park, Eun-Sun Jin, JoongKee Min, Sang Ryong Jeon, Dong Kyu Kim, Kyoung Hyo Choi, Adipose tissue-derived stem cells in the ovariectomy-induced postmenopausal osteoporosis rat model, Tissue Engineering and Regenerative Medicine, 2014,

    CrossRef

  4. 4
    Klaus Jung, Michael Lein, Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014, 1846, 2, 425

    CrossRef

  5. 5
    Satoshi Nishizawa, Takeshi Inagaki, Akinori Iba, Kazuro Kikkawa, Yoshiki Kodama, Nagahide Matsumura, Yasuo Kohjimoto, Isao Hara, Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade, SpringerPlus, 2014, 3, 1, 586

    CrossRef

  6. 6
    Aline G. Costa, John P. Bilezikian, Bone Turnover Markers in Primary Hyperparathyroidism, Journal of Clinical Densitometry, 2013, 16, 1, 22

    CrossRef

  7. 7
    Eduardo Kanterewicz, Pilar Peris, Emma Puigoriol, Aina Yáñez, Pau Rosique, Luis del Rio, Distribution of serum βCTX in a population-based study of postmenopausal women taking into account different anti-osteoporotic therapies (the FRODOS Cohort), Journal of Bone and Mineral Metabolism, 2013, 31, 2, 231

    CrossRef

  8. 8
    G. Maruani, N. Cornière, L. Nicolet, S. Baron, M. Courbebaisse, S. Renaud, P. Houillier, Hyperparathyroïdie primitive, La Revue de Médecine Interne, 2013, 34, 10, 605

    CrossRef

  9. 9
    Tao He, Wen Wu, Yan Huang, Xiaoling Zhang, Tingting Tang, Kerong Dai, Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty, International Orthopaedics, 2013, 37, 6, 1025

    CrossRef

  10. 10
    Pawel Szulc, Douglas C. Bauer, Osteoporosis, 2013,

    CrossRef

  11. You have free access to this content11
    Naoto Kamiya, Hiroyoshi Suzuki, Takumi Endo, Masashi Yano, Makito Naoi, Daisuke Nishimi, Koji Kawamura, Takashi Imamoto, Tomohiko Ichikawa, Clinical usefulness of bone markers in prostate cancer with bone metastasis, International Journal of Urology, 2012, 19, 11
  12. 12
    Miguel Angel Arrabal-Polo, Miguel Arrabal-Martin, Antonio Poyatos-Andujar, Encarnacion Cardenas-Grande, Sergio Merino-Salas, Armando Zuluaga-Gomez, Is the fasting calcium/creatinine a bone resorption marker in patients with calcium renal stones?, Urological Research, 2012, 40, 3, 243

    CrossRef

  13. 13
    Miguel Angel Arrabal-Polo, Miguel Arrabal-Martin, Maria Sierra Girón-Prieto, Antonio Poyatos-Andujar, Juan Garrido-Gomez, Armando Zuluaga-Gomez, Salvador Arias-Santiago, Osteopenia/osteoporosis in patients with calcium nephrolithiasis, Urological Research, 2012, 40, 6, 709

    CrossRef

  14. 14
    Klaus Jung, Kurt Miller, Manfred Wirth, Michael Albrecht, Michael Lein, Bone Turnover Markers as Predictors of Mortality Risk in Prostate Cancer Patients with Bone Metastases Following Treatment with Zoledronic Acid, European Urology, 2011, 59, 4, 604

    CrossRef

  15. 15
    Miguel Angel Arrabal-Polo, Miguel Arrabal-Martin, Tomas de Haro-Munoz, Victor M. Lopez-Leon, Sergio Merino-Salas, Miguel Angel Ochoa-Hortal, Juan Garrido-Gomez, Clara Lahoz-Garcia, Armando Zuluaga-Gomez, Mineral density and bone remodelling markers in patients with calcium lithiasis, BJU International, 2011, 108, 11
  16. 16
    Ramin Tolouian, German T. Hernandez, Wen-Yuan Chiang, Ajay Gupta, A new approach for evaluating bone turnover in chronic kidney disease, European Journal of Internal Medicine, 2010, 21, 3, 230

    CrossRef

  17. 17
    H. Kaji, Y. Kuroki, Y. Murakawa, I. Funakawa, Y. Funasaka, F. Kanda, T. Sugimoto, Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study, Osteoporosis International, 2010, 21, 9, 1565

    CrossRef

  18. 18
    Naoto Kamiya, Hiroyoshi Suzuki, Masashi Yano, Takumi Endo, Makoto Takano, Atsuhi Komaru, Koji Kawamura, Nobuyuki Sekita, Takashi Imamoto, Tomohiko Ichikawa, Implications of Serum Bone Turnover Markers in Prostate Cancer Patients With Bone Metastasis, Urology, 2010, 75, 6, 1446

    CrossRef

  19. 19
    Thomas Lund, Niels Abildgaard, Thomas L. Andersen, Jean-Marie Delaisse, Torben Plesner, Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*, European Journal of Haematology, 2010, 84, 5
  20. 20
    Seiji Ohtori, Tsutomu Akazawa, Yasuaki Murata, Tomoaki Kinoshita, Masaomi Yamashita, Koichi Nakagawa, Gen Inoue, Junichi Nakamura, Sumihisa Orita, Nobuyasu Ochiai, Shunji Kishida, Masashi Takaso, Yawara Eguchi, Kazuyo Yamauchi, Munetaka Suzuki, Yasuchika Aoki, Kazuhisa Takahashi, Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures, Journal of Clinical Neuroscience, 2010, 17, 2, 209

    CrossRef

  21. 21
    Tsu-Yi Chao, Yi-Ying Wu, Anthony J. Janckila, Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis, Clinica Chimica Acta, 2010, 411, 21-22, 1553

    CrossRef

  22. 22
    E Terpos, M A Dimopoulos, O Sezer, D Roodman, N Abildgaard, R Vescio, P Tosi, R Garcia-Sanz, F Davies, A Chanan-Khan, A Palumbo, P Sonneveld, M T Drake, J-L Harousseau, K C Anderson, B G M Durie, The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group, Leukemia, 2010, 24, 10, 1700

    CrossRef

  23. 23
    Markus J. Seibel, Bone Cancer, 2010,

    CrossRef

  24. 24
    J. del Pino Montes, L. Corral Gudino, C. Montilla Morales, S. Gómez Castro, Métodos complementarios en el diagnóstico y seguimiento de la osteoporosis, Revista Clínica Española, 2009, 209, 23

    CrossRef

  25. 25
    Signe Engkjær Christensen, Peter H. Nissen, Peter Vestergaard, Lene Heickendorff, Lars Rejnmark, Kim Brixen, Leif Mosekilde, Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism, Clinical Endocrinology, 2009, 71, 6
  26. 26
    Yoko Tarumi, Textbook of Palliative Medicine, 2009,

    CrossRef

  27. 27
    A. D. Anastasilakis, D. G. Goulis, S. A. Polyzos, S. Gerou, G. N. Koukoulis, Z. Efstathiadou, M. Kita, A. Avramidis, Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial, International Journal of Clinical Practice, 2008, 62, 6
  28. 28
    Yoshihiro Abe, Hitoshi Ishikawa, Akira Fukao, Higher Efficacy of Urinary Bone Resorption Marker Measurements in Assessing Response to Treatment for Osteoporosis in Postmenopausal Women, The Tohoku Journal of Experimental Medicine, 2008, 214, 1, 51

    CrossRef

  29. 29
    Yasuo Kuroki, Hiroshi Kaji, Seiji Kawano, Fumio Kanda, Yutaka Takai, Michiko Kajikawa, Toshitsugu Sugimoto, Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study, Journal of Bone and Mineral Metabolism, 2008, 26, 3, 271

    CrossRef

  30. 30
    Markus Herrmann, Markus Seibel, The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review, Clinica Chimica Acta, 2008, 393, 2, 57

    CrossRef

  31. 31
    Markus J. Seibel, The use of molecular markers of bone turnover in the management of patients with metastatic bone disease, Clinical Endocrinology, 2008, 68, 6
  32. 32
    Serge Cremers, Patrick Garnero, Markus J Seibel, Principles of Bone Biology, 2008,

    CrossRef

  33. 33
    I.N.G. Springer, J. Wiltfang, A. Dunsche, G.C. Lier, M. Bartsch, P.H. Warnke, E.L. Barth, H. Terheyden, Paul A.J. Russo, N. Czech, Y. Acil, A new method of monitoring osteomyelitis, International Journal of Oral and Maxillofacial Surgery, 2007, 36, 6, 527

    CrossRef

  34. 34
    K. Henriksen, L. B. Tanko, P. Qvist, P. D. Delmas, C. Christiansen, M. A. Karsdal, Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases, Osteoporosis International, 2007, 18, 5, 681

    CrossRef

  35. 35
    Axel Hegele, Hans Günther Wahl, Zoltan Varga, Selim Sevinc, Liseta Koliva, Andres Jan Schrader, Rainer Hofmann, Peter Olbert, Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer, BJU International, 2007, 99, 2
  36. 36
    Geoffrey L. Uy, Rachna Trivedi, Shachar Peles, Nicholas M. Fisher, Qin (Jean) Zhang, Michael H. Tomasson, John F. DiPersio, Ravi Vij, Bortezomib Inhibits Osteoclast Activity in Patients with Multiple Myeloma, Clinical Lymphoma and Myeloma, 2007, 7, 9, 587

    CrossRef

  37. 37
    Allan Lipton, Richard J. Cook, Robert E. Coleman, Matthew R. Smith, Pierre Major, Evangelos Terpos, James R. Berenson, Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma, Clinical Lymphoma and Myeloma, 2007, 7, 5, 346

    CrossRef

  38. 38
    Dora Beke, Stefan Kudlacek, Johannes G. Meran, Klinische Relevanz von Biomarkern bei der Skelettmetastasierung von Malignomen, Wiener Medizinische Wochenschrift, 2007, 157, 15-16, 375

    CrossRef

  39. 39
    Byung Joo Song, Seon Wook Cha, Ja Seong Bae, Young Jin Seo, Woo Chan Park, Han-Seong Kim, Se Jung Oh, Jeong Soo Kim, Sang Seol Jung, Role of Zoledronic Acid on Bone Loss by Letrozole, Journal of Breast Cancer, 2007, 10, 1, 43

    CrossRef

  40. 40
    Michael Lein, Manfred Wirth, Kurt Miller, Hans-Udo Eickenberg, Lothar Weißbach, Katja Schmidt, Ulrike Haus, Carsten Stephan, Sven Meissner, Stefan A. Loening, Klaus Jung, Serial Markers of Bone Turnover in Men with Metastatic Prostate Cancer Treated with Zoledronic Acid for Detection of Bone Metastases Progression, European Urology, 2007, 52, 5, 1381

    CrossRef

  41. 41
    J. E. Brown, E. V. McCloskey, J. A. Dewar, J. J. Body, D. A. Cameron, A. N. Harnett, M. Ruutu, O. P. Purohit, R. Tähtelä, R. E. Coleman, The Use of Bone Markers in a 6-Week Study to Assess the Efficacy of Oral Clodronate in Patients with Metastatic Bone Disease, Calcified Tissue International, 2007, 81, 5, 341

    CrossRef

  42. 42
    Evangelos Terpos, Biochemical markers of bone metabolism in multiple myeloma, Cancer Treatment Reviews, 2006, 32, 15

    CrossRef

  43. 43
    Mohammad Arabmotlagh, Robert Sabljic, Markus Rittmeister, Changes of the Biochemical Markers of Bone Turnover and Periprosthetic Bone Remodeling After Cemented Hip Arthroplasty, The Journal of Arthroplasty, 2006, 21, 1, 129

    CrossRef

  44. 44
    Takayuki Hamano, Naohiko Fujii, Yasuyuki Nagasawa, Yoshitaka Isaka, Toshiki Moriyama, Noriyuki Okada, Enyu Imai, Masaru Horio, Takahito Ito, Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease, Bone, 2006, 39, 5, 1067

    CrossRef

  45. 45
    Tuan V. Nguyen, Christian Meier, Markus J. Seibel, Dynamics of Bone and Cartilage Metabolism, 2006,

    CrossRef

  46. 46
    Andreas Grauer, Ethel Siris, Stuart Ralston, Dynamics of Bone and Cartilage Metabolism, 2006,

    CrossRef

  47. 47
    Jean-Jacques Body, Dynamics of Bone and Cartilage Metabolism, 2006,

    CrossRef

  48. 48
    Markus J Seibel, Clinical use of markers of bone turnover in metastatic bone disease, Nature Clinical Practice Oncology, 2005, 2, 10, 504

    CrossRef

  49. 49
    Dimitrios Pectasides, Dimitrios Farmakis, Maria Nikolaou, Ioannis Kanakis, Vassiliki Kostopoulou, Ioannis Papaconstantinou, Nikolaos K. Karamanos, Theofanis Economopoulos, Sotirios A. Raptis, Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer, Journal of Pharmaceutical and Biomedical Analysis, 2005, 37, 1, 171

    CrossRef

  50. 50
    Christian Meier, Peter Y. Liu, David J. Handelsman, Markus J. Seibel, Endocrine regulation of bone turnover in men, Clinical Endocrinology, 2005, 63, 6
  51. 51
    Hubert W. Vesper, REVIEW: Analytical and Preanalytical Issues in Measurement of Biochemical Bone Markers, Laboratory Medicine, 2005, 36, 7, 424

    CrossRef

  52. 52
    Riitta Tähtelä, J. Seppänen, K. Laitinen, A. Katajamäki, J. Risteli, M. J. Välimäki, Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide, Osteoporosis International, 2005, 16, 9, 1109

    CrossRef

  53. 53
    Evangelos Terpos, Marianna Politou, Amin Rahemtulla, The role of markers of bone remodeling in multiple myeloma, Blood Reviews, 2005, 19, 3, 125

    CrossRef

  54. 54
    Irina Lendel, Melvin Horwith, An update from the latest workshop on asymptomatic primary hyperparathyroidism, Otolaryngologic Clinics of North America, 2004, 37, 4, 737

    CrossRef

  55. 55
    Ian R Reid, James S Davidson, Diana Wattie, Fiona Wu, Jenny Lucas, Gregory D Gamble, Michael D Rutland, Tim Cundy, Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone, Bone, 2004, 35, 1, 224

    CrossRef

  56. 56
    Klaus Jung, Michael Lein, Carsten Stephan, Katharina Von Hösslin, Axel Semjonow, Pranav Sinha, Stefan A. Loening, Dietmar Schnorr, Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implications, International Journal of Cancer, 2004, 111, 5
  57. 57
    A. Montagnani, S. Gonnelli, C. Cepollaro, M. Mangeri, S. Martini, M.B. Franci, M.S. Campagna, B. Lucani, N. Di Paolo, G. Bellucci, C. Gennari, A new serum assay to measure N-terminal fragment of telopeptide of type I collagen in patients with renal osteodystrophy, European Journal of Internal Medicine, 2003, 14, 3, 172

    CrossRef

  58. 58
    Jun SATO, Reeko SATO, Aiko TAKAGI, Taichi GOTO, Keiji OKADA, Jun YASUDA, Yoshihisa NAITO, Association between Changes in Plasma Calcium Concentration and Plasma Tartrate-Resistant Acid Phosphatase Activity in Periparturient Cows, Journal of Veterinary Medical Science, 2003, 65, 2, 291

    CrossRef

  59. 59
    Aparna Mahakala, Shalini Thoutreddy, Michael Kleerekoper, Prevention and Treatment of Postmenopausal Osteoporosis, Treatments in Endocrinology, 2003, 2, 5, 331

    CrossRef

  60. 60
    KE Naylor, B Jackson, R Eastell, The Renal Clearance of Free and Peptide-Bound Deoxypyridinoline: Response to Pamidronate Treatment of Paget's Disease, Journal of Bone and Mineral Research, 2003, 18, 4
  61. 61
    Richard E. Clark, William D. Fraser, Bone Turnover Following Autologous Transplantation in Multiple Myeloma, Leukemia & Lymphoma, 2002, 43, 3, 511

    CrossRef

  62. 62
    Edward A Schober, Steffen J Breusch, Ulrich Schneider, Instability and variability of urinary telopeptides and free crosslinks, Clinica Chimica Acta, 2002, 324, 1-2, 73

    CrossRef

  63. 63
    Markus Herrmann, Gerd Pape, Wolfgang Herrmann, Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions, Clinical Chemistry and Laboratory Medicine, 2002, 40, 8

    CrossRef

  64. 64
    R J Wenstrup, M Roca-Espiau, N J Weinreb, B Bembi, Skeletal aspects of Gaucher disease: a review, The British Journal of Radiology, 2002, 75, suppl_1, A2

    CrossRef

  65. 65
    Robert E. Coleman, The clinical use of bone resorption markers in patients with malignant bone disease, Cancer, 2002, 94, 10
  66. 66
    M. Davies, W. D. Fraser, D. J. Hosking, The management of primary hyperparathyroidism, Clinical Endocrinology, 2002, 57, 2
  67. 67
    James R. Berenson, Robert Vescio, Kathryn Henick, Carol Nishikubo, Matthew Rettig, Regina A. Swift, Francisco Conde, Joseph M. Von Teichert, A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease, Cancer, 2001, 91, 1
  68. 68
    Henning W. Woitge, Markus J. Seibel, Biochemical Markers to Survey Bone Turnover, Rheumatic Disease Clinics of North America, 2001, 27, 1, 49

    CrossRef

  69. 69
    F. Branca, A. B. Hanley, B Pool-Zobel, H. Verhagen, Biomarkers in disease and health, British Journal of Nutrition, 2001, 86, S1, S55

    CrossRef

  70. 70
    P. Pietschmann, S. Kudlacek, J. Grisar, S. Spitzauer, W. Woloszczuk, R. Willvonseder, M. Peterlik, Bone turnover markers and sex hormones in men with idiopathic osteoporosis, European Journal of Clinical Investigation, 2001, 31, 5
  71. 71
    P. Mikosch, B. Jauk, H.J. Gallowitsch, W. Pipam, E. Kresnik, P. Lind, Suppressive Levothyroxine Therapy has no Significant Influence on Bone Degradation in Women with Thyroid Carcinoma: A Comparison with Other Disorders Affecting Bone Metabolism, Thyroid, 2001, 11, 3, 257

    CrossRef

  72. 72
    Markus J. Seibel, The Parathyroids, 2001,

    CrossRef

  73. 73
    Vladimir Palicka, Antonin Jabor, Bedrich Friedecky, Pavel Zivny, Advances in Clinical Chemistry Volume 35, 2001,

    CrossRef

  74. 74
    Tuan V. Nguyen, John A. Eisman, Assessment of Significant Change in BMD: A New Approach, Journal of Bone and Mineral Research, 2000, 15, 2
  75. 75
    E. Romagnoli, I. Colangeli, S. Minisola, Awareness, attitudes and opinions on osteoporosis of primary care physicians working in the metropolitan area of Rome: A brief report, Aging Clinical and Experimental Research, 2000, 12, 3, 240

    CrossRef

  76. 76
    R. Eastell, N. Mallinak, S. Weiss, M. Ettinger, M. Pettinger, D. Cain, K. Flessland, C. Chesnut, Biological Variability of Serum and Urinary N-Telopeptides of Type I Collagen in Postmenopausal Women, Journal of Bone and Mineral Research, 2000, 15, 3
  77. 77
    L. Alvarez, C. RicÓs, P. Peris, N. GuaÑabens, A. Monegal, F. Pons, A.M. Ballesta, Components of biological variation of biochemical markers of bone turnover in Paget’s bone disease, Bone, 2000, 26, 6, 571

    CrossRef

  78. 78
    Franca Pagani, Graziella Bonetti, Francesca Stefini, Mauro Panteghini, Evaluation of a Fully Automated Assay to Measure C-Telopeptide of Type I Collagen in Serum, Clinical Chemistry and Laboratory Medicine, 2000, 38, 11

    CrossRef

  79. 79
    A. Fontana, Pierre D. Delmas, Markers of bone turnover in bone metastases, Cancer, 2000, 88, S12
  80. 80
    R.D Chapurlat, P Garnero, G Brárt, P.J Meunier, P.D Delmas, Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women:, Bone, 2000, 27, 2, 283

    CrossRef

  81. 81
    Jussi M. Halleen, Sari L. Alatalo, Harri Suominen, Sulin Cheng, Anthony J. Janckila, H. Kalervo Väänänen, Tartrate-Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption, Journal of Bone and Mineral Research, 2000, 15, 7